Congenital myasthenic syndromes Minigene Neuromuscular junction Cholinergic Dimerization MuSK Drainage Chemokines Congenital myasthenic syndrome Amyotrophic Lateral Sclerosis/genetics Lithium chloride Acetylcholinesterase Amyotrophic lateral sclerosis Amyloid Knockout mouse GFPT1 Rare diseases Conduction disease Nondystrophic myotonias Congenital myopathy Distal myopathy Frontotemporal Dementia/genetics Jonction neuro musculaire Receptors Cell Cycle Proteins/chemistry/genetics/metabolism Wnt Database COVID-19 Biological Markers Hypokalaemic periodic paralysis Deficiency Calcium channel LRP4 Precision medicine Hereditary/genetics Female Mexiletine Aged CMS Cluster Analysis Ca V Adult SMA Agrin Developmental Multiple sclerosis HEK293 Cells Autoimmune Myotonia congenita 80 and over ALS HDAC motor neuron neuromuscular junction reinnervation Gene Expression Regulation Non-dystrophic myotonia Jonction Neuromusculaire NMJ Clinical trial Synaptotagmin2 Heart failure IL-22 binding protein isoform Cytokines Experimental disease models MBNL Paramyotonia congenita Actin cytoskeleton Humans Jonction neuromusculaire HSP70 Heat-Shock Proteins/genetics/metabolism Body Patterning Motoneuron Longitudinal progression Expression Acetyltransferase M3243AG Epidemiology Awareness Cognitive decline Genetic Association Studies Aging Cell-cell communication Animals Myotonic Dystrophy Frontotemporal lobar degeneration NMJ Butyrylcholinesterase Cercopithecus aethiops Acetylcholine receptor clustering Diseases COS Cells Disability Chloride channel Embryo Neuromuscular disease Alzheimer's disease Actionable genes Gating pore current Abbreviations CMAP ¼ compound muscle action potential CLS HypoPP ¼ hypokalaemic periodic paralysis Clinical trials Brain Treatment delay Mutation IL22RA2